治疗他类药物后的严重肌痛性肌痛症:目标试验仿真和自我控制病例系列研究的证据
Wanchun Xu1, Vincent Ka Chun Yan2, Zhijuan Zhang1
1Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Nature communications
|November 28, 2024
概括
静止剂的使用可能会增加肌痛性骨髓灰质炎 (MG) 发病和恶化的风险,特别是在前几个月. 建议在开始服用他类药物后至少六个月监测MG症状.
科学领域:
- 药物监督 药物监督 药物监督
- 神经学 神经学
- 流行病学 流行病学
背景情况:
- 国际机构已经标记了与他类药物治疗相关的潜在肌痛性痛风 (MG) 风险.
- 了解这种关联对于患者安全和临床实践至关重要.
研究的目的:
- 调查他类药物使用与肌痛性骨髓灰质炎 (MG) 发病和恶化的风险之间的关联.
- 确定在开始使用他类药物治疗的患者中MG症状的适当监测期.
主要方法:
- 使用了来自香港的基于人口的电子健康记录.
- 针对性试验模拟 (TTE) 和自我控制病例系列 (SCCS) 的研究设计被用于强大的分析.
主要成果:
- 立方体治疗与MG发病和恶化的发病率增加有关,特别是在前七个月内.
- 针对MG发病的调整后危险比率 (HR) 在第一个月是最高的 (HR:6.11),并在第七个月保持升高.
- 在开始服用他类药物18个月后,没有观察到风险增加,在SCCS分析中也有类似的模式.
结论:
- 这项研究支持了他类药物使用与肌痛性骨髓灰质炎 (MG) 风险增加之间的潜在联系.
- 对于开始治疗他类药物的患者,建议对MG症状进行至少六个月的监测期.
- 这些发现有助于完善他类药物使用者的药监策略.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Myasthenia Gravis: Diagnostic Tests
653
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
653
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
536
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
536
Disorders of the Skeletal Muscle
879
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
879
Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2


